Size	B:C0456389
-	O
selective	O
separation	O
and	O
overall	O
-	O
amplification	O
of	O
cell	O
-	O
free	O
fetal	O
DNA	O
fragments	O
using	O
PCR	O
-	I:C0022885
based	I:C0022885
enrichment	I:C0022885
.	O

Size	O
-	O
selective	O
separation	O
and	O
overall	O
-	O
amplification	B:C0683230
of	O
cell	O
-	O
free	O
fetal	O
DNA	O
fragments	O
using	O
PCR	O
-	I:C0022885
based	I:C0022885
enrichment	I:C0022885
.	O

Size	O
-	O
selective	O
separation	O
and	O
overall	O
-	O
amplification	O
of	O
cell	O
-	O
free	O
fetal	O
DNA	O
fragments	O
using	O
PCR	B:C0022885
-	I:C0022885
based	I:C0022885
enrichment	I:C0022885
.	O

This	O
study	B:C0008972
aimed	O
to	O
establish	O
a	O
method	O
for	O
the	O
selective	O
amplification	I:C0683230
of	O
cell	O
-	O
free	O
fetal	O
DNA	O
(	O
cffDNA	O
)	O
in	O
maternal	O
plasma	O
and	O
preserve	O
the	O
integrity	O
of	O
DNA	O
fragments	O
during	O
amplification	O
,	O
thereby	O
providing	O
a	O
sufficient	O
amount	O
of	O
cffDNA	O
to	O
meet	O
the	O
requirement	O
of	O
routine	O
non-invasive	O
prenatal	O
testing	O
.	O

This	O
study	O
aimed	O
to	O
establish	O
a	O
method	O
for	O
the	O
selective	B:C0683230
amplification	I:C0683230
of	O
cell	O
-	O
free	O
fetal	O
DNA	O
(	O
cffDNA	O
)	O
in	O
maternal	O
plasma	O
and	O
preserve	O
the	O
integrity	O
of	O
DNA	O
fragments	O
during	O
amplification	O
,	O
thereby	O
providing	O
a	O
sufficient	O
amount	O
of	O
cffDNA	O
to	O
meet	O
the	O
requirement	O
of	O
routine	O
non-invasive	O
prenatal	O
testing	O
.	O

This	O
study	O
aimed	O
to	O
establish	O
a	O
method	O
for	O
the	O
selective	O
amplification	I:C0683230
of	O
cell	O
-	O
free	O
fetal	O
DNA	O
(	O
cffDNA	O
)	O
in	O
maternal	B:C1858460
plasma	O
and	O
preserve	O
the	O
integrity	O
of	O
DNA	O
fragments	O
during	O
amplification	O
,	O
thereby	O
providing	O
a	O
sufficient	O
amount	O
of	O
cffDNA	O
to	O
meet	O
the	O
requirement	O
of	O
routine	O
non-invasive	O
prenatal	O
testing	O
.	O

This	O
study	O
aimed	O
to	O
establish	O
a	O
method	O
for	O
the	O
selective	O
amplification	I:C0683230
of	O
cell	O
-	O
free	O
fetal	O
DNA	O
(	O
cffDNA	O
)	O
in	O
maternal	O
plasma	B:C0032105
and	O
preserve	O
the	O
integrity	O
of	O
DNA	O
fragments	O
during	O
amplification	O
,	O
thereby	O
providing	O
a	O
sufficient	O
amount	O
of	O
cffDNA	O
to	O
meet	O
the	O
requirement	O
of	O
routine	O
non-invasive	O
prenatal	O
testing	O
.	O

This	O
study	O
aimed	O
to	O
establish	O
a	O
method	O
for	O
the	O
selective	O
amplification	I:C0683230
of	O
cell	O
-	O
free	O
fetal	O
DNA	O
(	O
cffDNA	O
)	O
in	O
maternal	O
plasma	O
and	O
preserve	O
the	O
integrity	O
of	O
DNA	O
fragments	O
during	O
amplification	B:C0683230
,	O
thereby	O
providing	O
a	O
sufficient	O
amount	O
of	O
cffDNA	O
to	O
meet	O
the	O
requirement	O
of	O
routine	O
non-invasive	O
prenatal	O
testing	O
.	O

We	O
amplified	O
DNA	B:C0012854
molecules	I:C0012854
in	O
a	O
one	O
-	O
reaction	O
system	O
without	O
considering	O
their	O
particular	O
sequences	O
and	O
lengths	O
(	O
overall	O
amplification	O
)	O
by	O
using	O
PCR	O
-	I:C0022885
based	I:C0022885
enrichment	I:C0022885
.	O

We	O
amplified	O
DNA	O
molecules	I:C0012854
in	O
a	O
one	O
-	O
reaction	O
system	O
without	O
considering	O
their	O
particular	O
sequences	B:C0162326
and	O
lengths	O
(	O
overall	O
amplification	O
)	O
by	O
using	O
PCR	O
-	I:C0022885
based	I:C0022885
enrichment	I:C0022885
.	O

We	O
amplified	O
DNA	O
molecules	I:C0012854
in	O
a	O
one	O
-	O
reaction	O
system	O
without	O
considering	O
their	O
particular	O
sequences	O
and	O
lengths	O
(	O
overall	O
amplification	B:C0683230
)	O
by	O
using	O
PCR	O
-	I:C0022885
based	I:C0022885
enrichment	I:C0022885
.	O

We	O
amplified	O
DNA	O
molecules	I:C0012854
in	O
a	O
one	O
-	O
reaction	O
system	O
without	O
considering	O
their	O
particular	O
sequences	O
and	O
lengths	O
(	O
overall	O
amplification	O
)	O
by	O
using	O
PCR	B:C0022885
-	I:C0022885
based	I:C0022885
enrichment	I:C0022885
.	O

We	O
then	O
modified	O
PCR	B:C0032520
conditions	O
to	O
verify	O
the	O
effect	O
of	O
denaturation	O
temperature	O
on	O
DNA	O
amplification	I:C0683230
on	O
various	O
lengths	O
of	O
DNA	O
(	O
selective	O
overall	O
amplification	O
)	O
.	O

We	O
then	O
modified	O
PCR	O
conditions	O
to	O
verify	O
the	O
effect	O
of	O
denaturation	O
temperature	O
on	O
DNA	B:C0683230
amplification	I:C0683230
on	O
various	O
lengths	O
of	O
DNA	O
(	O
selective	O
overall	O
amplification	O
)	O
.	O

We	O
then	O
modified	O
PCR	O
conditions	O
to	O
verify	O
the	O
effect	O
of	O
denaturation	O
temperature	O
on	O
DNA	O
amplification	I:C0683230
on	O
various	O
lengths	O
of	O
DNA	B:C0012854
(	O
selective	O
overall	O
amplification	O
)	O
.	O

We	O
then	O
modified	O
PCR	O
conditions	O
to	O
verify	O
the	O
effect	O
of	O
denaturation	O
temperature	O
on	O
DNA	O
amplification	I:C0683230
on	O
various	O
lengths	O
of	O
DNA	O
(	O
selective	O
overall	O
amplification	B:C0683230
)	O
.	O

Finally	O
,	O
we	O
used	O
an	O
optimum	O
temperature	O
range	O
to	O
amplify	B:C0683230
cffDNA	O
selectively	O
.	O

Amplification	B:C0683230
results	O
were	O
validated	O
by	O
electrophoresis	O
and	O
real	O
-	I:C3179034
time	I:C3179034
quantitative	I:C3179034
PCR	I:C3179034
.	O

Amplification	O
results	O
were	O
validated	O
by	O
electrophoresis	B:C0013855
and	O
real	O
-	I:C3179034
time	I:C3179034
quantitative	I:C3179034
PCR	I:C3179034
.	O

Amplification	O
results	O
were	O
validated	O
by	O
electrophoresis	O
and	O
real	B:C3179034
-	I:C3179034
time	I:C3179034
quantitative	I:C3179034
PCR	I:C3179034
.	O

Our	O
PCR	B:C0022885
-	I:C0022885
based	I:C0022885
enrichment	I:C0022885
efficiently	O
amplified	O
all	O
DNA	O
fragments	O
with	O
differing	O
lengths	O
within	O
a	O
single	O
reaction	O
system	O
,	O
as	O
well	O
as	O
preserving	O
the	O
integrity	O
of	O
the	O
DNA	O
fragments	O
.	O

cffDNA	O
was	O
significantly	O
amplified	O
along	O
with	O
the	O
selective	B:C0683230
amplification	I:C0683230
of	O
small	O
fragment	O
maternal	O
plasma	O
DNA	O
in	O
an	O
appropriate	O
range	O
of	O
denaturation	O
temperatures	O
.	O

cffDNA	O
was	O
significantly	O
amplified	O
along	O
with	O
the	O
selective	O
amplification	I:C0683230
of	O
small	O
fragment	O
maternal	B:C1858460
plasma	O
DNA	O
in	O
an	O
appropriate	O
range	O
of	O
denaturation	O
temperatures	O
.	O

cffDNA	O
was	O
significantly	O
amplified	O
along	O
with	O
the	O
selective	O
amplification	I:C0683230
of	O
small	O
fragment	O
maternal	O
plasma	B:C0032105
DNA	O
in	O
an	O
appropriate	O
range	O
of	O
denaturation	O
temperatures	O
.	O

cffDNA	O
was	O
significantly	O
amplified	O
along	O
with	O
the	O
selective	O
amplification	I:C0683230
of	O
small	O
fragment	O
maternal	O
plasma	O
DNA	B:C0012854
in	O
an	O
appropriate	O
range	O
of	O
denaturation	O
temperatures	O
.	O

We	O
have	O
established	O
a	O
PCR	B:C0032520
-	I:C0032520
based	I:C0032520
method	I:C0032520
for	O
the	O
simultaneous	O
enrichment	O
and	O
amplification	O
of	O
cffDNA	O
in	O
order	O
to	O
meet	O
the	O
requirements	O
of	O
high	O
cffDNA	O
quantity	O
for	O
routine	O
non-invasive	O
prenatal	O
testing	O
.	O

We	O
have	O
established	O
a	O
PCR	O
-	I:C0032520
based	I:C0032520
method	I:C0032520
for	O
the	O
simultaneous	O
enrichment	B:C0022885
and	O
amplification	O
of	O
cffDNA	O
in	O
order	O
to	O
meet	O
the	O
requirements	O
of	O
high	O
cffDNA	O
quantity	O
for	O
routine	O
non-invasive	O
prenatal	O
testing	O
.	O

We	O
have	O
established	O
a	O
PCR	O
-	I:C0032520
based	I:C0032520
method	I:C0032520
for	O
the	O
simultaneous	O
enrichment	O
and	O
amplification	B:C0683230
of	O
cffDNA	O
in	O
order	O
to	O
meet	O
the	O
requirements	O
of	O
high	O
cffDNA	O
quantity	O
for	O
routine	O
non-invasive	O
prenatal	O
testing	O
.	O

